Trial Profile
Study of patients with atrial fibrillation experiencing a major bleeding event while on rivaroxaban
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Sep 2018
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Stroke
- Focus Adverse reactions
- 11 Sep 2018 New trial record